GM2 Activator Deficiency is referred
to as the AB variant of GM2 Gangliosidosis and is similar to the features
of the other variants, Tay-Sachs Disease and Sandhoff Disease. The
disorder is caused by lack of the GM2 Activator that facilitates the breakdown
of ganglioside by beta-hexosaminidase A, resulting in an accumulation of
ganglioside, as in the other GM2 Gangliosidosis variants.